| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | Feb 5, 2024 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 86.3 | +99,518 | 6.41% | ✓ | $23.1K |
| Dec 1, 2021 | Dec 3, 2021 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 20.0 | -200,000 | -11.97% | ✓ | $1M |
| Aug 13, 2018 | Aug 15, 2018 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 43.8 | -4,250 | -0.25% | ✗ | $40.4K |
| Aug 13, 2018 | Aug 14, 2018 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 43.8 | -4,250 | -0.25% | ✗ | $40.4K |
| Jul 11, 2018 | Jul 13, 2018 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 47.5 | -10,000 | -0.59% | ✓ | $100K |
| Jul 6, 2018 | Jul 10, 2018 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 45.0 | -20,000 | -1.17% | ✓ | $173.6K |
| Jul 3, 2018 | Jul 6, 2018 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 45.0 | -20,000 | -1.16% | ✓ | $164K |
| Oct 3, 2017 | Oct 5, 2017 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 47.5 | -10,000 | -0.58% | ✓ | $80K |
| Aug 15, 2017 | Aug 17, 2017 | Arbutus Biopharma Corp | Chief Scientific Officer | Sell | 22.5 | -30,000 | -1.70% | ✗ | $111K |